PRIMARY STUDY
Buccally Absorbed Cannabidiol Shows Significantly Superior Pain Control and Improved Satisfaction Immediately After Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, Double-Blinded, Randomized Trial
Key Findings: Patients given sublingual cannabidiol (CBD) following arthroscopic rotator cuff repair (ARCR) had improved pain scores compared to placebo.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 99
Study Result: Positive
Research Location(s): United States
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Dosage: 25-50 mg of CBD 3 times a day for 14 days
Route of Administration: Sublingual/Oromucosal
Citation: Alaia MJ, et al. Buccally Absorbed Cannabidiol Shows Significantly Superior Pain Control and Improved Satisfaction Immediately After Arthroscopic Rotator Cuff Repair: A Placebo-Controlled, Double-Blinded, Randomized Trial. Am J Sports Med. 2022; 50:3056-3063. doi: 10.1177/03635465221109573
Authors: Alaia MJ, Hurley ET, Vasavada K, Markus DH, Britton B, Gonzalez-Lomas G, Rokito AS, Jazrawi LM, Kaplan K
